This protocol describes an optimized two-step digestion method for isolating high-purity and high-viability primary cholangiocytes from wild-type mice and mice with polycystic liver disease.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This protocol describes an optimized two-step digestion method for isolating high-purity and high-viability primary cholangiocytes from wild-type mice and mice with polycystic liver disease.
In this protocol, we optimized a two-step digestion method to isolate high-purity and high-viability primary cholangiocytes from wild-type mice and mice with polycystic liver disease (PLD). After anesthetizing the mice, the livers were perfused through the inferior vena cava with 50 mL of Solution A, followed by 30 mL of Solution B at 37 °C to enzymatically digest the liver tissue. Mechanical dissociation, shaking, and microdissection were performed to remove adherent parenchymal cells, leaving an intact biliary tree. The biliary tree was then finely minced and digested with shaking for 60 min at 37 °C. The resulting single-cell suspension was collected using a 70 µm cell strainer. Cholangiocytes were purified using immunomagnetic isolation. The cell suspension was incubated with an anti-EpCAM antibody under rotation for 45 min at 4 °C, followed by the addition of Protein G beads and further rotation for another 45 min at 4 °C. After three washes with PBS, the cholangiocytes were collected using a magnetic separator. The purified primary cholangiocytes were resuspended in Cholangiocyte Culture Medium and seeded onto cell culture dishes coated with 1 mg/mL type I rat tail collagen. The purity of the cholangiocytes was confirmed by immunostaining for the cholangiocyte-specific marker cytokeratin-19 (CK19). Although this study focused on isolating primary cholangiocytes from wild-type and PLD mice, we are confident that the protocol can be applied to other disease mouse models as well. This detailed two-step digestion method facilitates in vitro studies of cholangiopathies and the development of targeted therapies.
Cholangiocytes, the epithelial cells lining the intrahepatic biliary tree, form a monolayer and constitute approximately 3-5% of the liver's total cell population1. These cells interconnect within the liver to create a complex three-dimensional ductal network2. Under normal conditions, cholangiocytes perform vital functions, including secretion, absorption, injury repair, and serving as an immune barrier, thereby playing a critical role in liver physiology and pathology. However, cholangiocyte dysfunction can lead to various diseases, including PLD, primary sclerosing cholangitis, cholangiocarcinoma, and cholestatic ....
Access restricted. Please log in or start a trial to view this content.
All mouse care and experimental protocols were approved by the Ethical Committee of Tianjin Medical University (Doc. No: TMUa-MEC 2022016).
1. Preparation of equipment and solutions
Access restricted. Please log in or start a trial to view this content.
The workflow diagram for the two-step digestion process used to isolate cholangiocytes is shown in Figure 1. The entire procedure takes ~5 h. First, the liver is perfused with Solution A through the inferior vena cava to remove blood, as indicated by the liver turning pale. The liver is then perfused with Solution B containing collagenase II to initiate tissue digestion. This initial digestion step is time-sensitive, and successful digestion is evidenced by t.......
Access restricted. Please log in or start a trial to view this content.
This protocol provides a detailed method for isolating high-purity primary cholangiocytes from mice using a two-step digestion process, enabling the study of the molecular mechanisms underlying cholangiopathies. Several critical steps are essential to ensure the successful isolation of cholangiocytes.
The first critical step is ensuring effective perfusion and digestion using Solution A and Solution B. Successful perfusion with Solution A was confirmed by the liver turning pale, and successful.......
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflicts of interest.
This work was supported by grants from the Tianjin Municipal Education Commission (2022ZD054 to L.Z.)
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 0.22 μm filter | PALL | 4612 | |
| 0.25% Trypsin | Gibco | 25200-056 | |
| 10 mL syringe | KONSMED | 10 mL 1.2*30TWLB | |
| 20 mL syringe | KONSMED | 20 mL 1.2*30TWLB | |
| 24 G intravenous catheter | WEGO | 24GX19 mm/Y-G | |
| 3,3',5-triiodo-L-thyronine | Sigma | T5516 | 1.7 mg/mL stock |
| 4% paraformaldehyde | Solarbio | P1110 | |
| 5 mL syringe | KONSMED | 5 mL 0.7*30TWLB | |
| 6 cm dishes | Thermo Scientific | 150462 | |
| 70 µm cell strainer | Corning | 352350 | |
| anti-CK19 antibody | DSHB | TROMA-III | |
| anti-EpCAM antibody | DSHB | G8.8 | |
| BSA | Solarbio | A8020 | |
| CaCl2 | Sangon Biotech | A501330 | 2 M stock |
| Chemically-defined lipid concentrate (100x) | Gibco | 11905-031 | |
| Collagenase II | Worthington | LS004176 | |
| Collagenase XI | Sigma | C7657 | 3.2 mg/mL stock |
| Dexamethasone | Sigma | D1756 | 10 mg/mL stock |
| Dissecting Microscope | Leica | EZ4 | |
| DMEM/F12 (1:1) | VivaCell biosciences | C3130-0500 | |
| DMSO | Sigma | D2650 | |
| DNase I | Sigma | D4513 | 10 U/μL stock |
| Donkey anti-rat Alexa Fluor 488 secondary antibody | Invitrogen | A21208 | |
| EGTA | Solarbio | E8050 | 50 mM (PH = 8) stock |
| Epidermal growth factor (1 mg/mL) | Sigma | SRP3196 | |
| Ethanolamine | Sigma | E9508 | |
| Fetal Bovine Serum | VivaCell biosciences | C04001-500 | |
| Forskolin | Sigma | F3917 | 20 mM stock |
| Gentamicin/amphotericin solution (500x) | Gibco | R01510 | |
| Hemocytometer | QIUJING | XB.K.25. | |
| HEPES | Sigma | H4034 | |
| Hyaluronidase | Sigma | H3506 | 10 mg/mL stock |
| Insulin-transferrin-selenium (100x) | Gibco | 41400045 | |
| Isoflurane | RWD | R510-22-10 | |
| KCl | Sangon Biotech | A100395 | |
| L-Glutamine (200 mM) | Sigma | G7513 | |
| Magnetic separator | Promega | Z5342 | |
| MEM non-essential amino acids (100x) | Gibco | 11140050 | |
| MEM vitamin solution (100x) | Gibco | 11120052 | |
| MgCl2 | Sangon Biotech | A100288 | 1.5 M stock |
| Na Pyruvate (100 mM) | Gibco | 11360070 | |
| Na2HPO4 | Sangon Biotech | A600487 | |
| NaCl | Sangon Biotech | A610476 | |
| NaOH | Sangon Biotech | A620617 | 1 N stock |
| PBS | VivaCell biosciences | C3580-0500 | |
| PBS | Solarbio | P1010 | |
| Penicillin-Streptomycin (100x) | Gibco | 15140-122 | |
| Peristaltic pump | BaodingRongbai | YZ1515PPS | |
| Protein G beads | Invitrogen | 10004D | |
| Rotator | Kylin-Bell | QB-528 | |
| RPMI | VivaCell biosciences | C3010-0500 | |
| Soybean trypsin inhibitor | Sigma | T6522 | 10 mg/mL stock |
| Swaged needle | Jinhuan Medical | HM601 | |
| Triton X-100 | Solarbio | T8200 | |
| Trypan blue | Sigma | T6146 | 10 mg/mL stock |
| Type I rat tail collagen | BD | 354236 |
Access restricted. Please log in or start a trial to view this content.
This article has been published
Video Coming Soon